Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment

The preclinical and clinical development of novel immunotherapies for the treatment of central nervous system (CNS) tumors is advancing at a rapid pace. High-grade gliomas (HGG) are aggressive tumors with poor prognoses in both adult and pediatric patients, and innovative and effective therapies are...

Descripción completa

Detalles Bibliográficos
Autores principales: Franson, Andrea, McClellan, Brandon L., Varela, Maria Luisa, Comba, Andrea, Syed, Mohammad Faisal, Banerjee, Kaushik, Zhu, Ziwen, Gonzalez, Nazareno, Candolfi, Marianela, Lowenstein, Pedro, Castro, Maria Graciela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515652/
https://www.ncbi.nlm.nih.gov/pubmed/36186781
http://dx.doi.org/10.3389/fmed.2022.966458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515652/
https://www.ncbi.nlm.nih.gov/pubmed/36186781
http://dx.doi.org/10.3389/fmed.2022.966458

Ejemplares similares